Although the mechanism of GSK3 modulation in the AD brain is far from completely understood, it is reasonable to speculate that the regulation of insulin deficiency in APP processing to the amyloidosis pathway is, at least partly, through activation of GSK3 signaling. The gene discussed is INS; the disease is hyperinsulinemic hypoglycemia, familial, 4.